At least in mice, induction of UCP1 by treatment with a β3-adrenaergic agonist increases both BAT thermogenesis and whole-body oxygen consumption, preventing the development of obesity [5]. Here, UCP1 is linked to obesity due to melanocortin 4 receptor deficiency.